Key facts
- EzeRX’s last known valuation is $8.9M (Oct 2023).
- It has raised $4.4M; the latest was Later Stage VC in Jul 2025.
- Notable investors include BIRAC, Bosch DNA Nxt Startup Alliance Program, Indian Oil Corporation, Infosys Foundation, KIIT Technology Business Incubator KIIT-TBI — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for EzeRX
- ·The full record, as it builds
Funding rounds
No funding rounds for EzeRX are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EzeRX
Developer of medical devices designed to deliver management of curative and preventive healthcare. The company offers non-invasive, contactless portable instruments that detect liver and lung problems at a lower cost, enabling healthcare professionals to get help in the early detection of ailments and proper diagnosis of patients' illnesses.
- Sector
- Healthcare
- HQ
- Bhubaneshwar, India
- Founded
- 2018
- Employees
- 56
- Website
- ezerx.in/
- Ownership
- Privately Held (backing)
EzeRX doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EzeRX shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EzeRX in its N-PORT filings yet. We sweep new filings monthly.